|
|
View Clinical Trial (Medical Research Study)
|
A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms - NCT01052103-92845 (Clinical Trial 478923)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy478923.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
Garden Grove |
|
State:
|
|
CA |
| Zip Code: |
|
92845 |
| Conditions: |
|
Schizophrenia |
| Purpose: |
|
The purpose of this study is to determine whether LY2140023, when added to standard-of-care
antipsychotic treatment, will improve negative symptoms.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Clinical diagnosis of schizophrenia
- Patients must have been receiving monotherapy treatment for at least 3 months prior
to study entry with one of 4 atypical antipsychotic medications (aripiprazole,
olanzapine, risperidone, quetiapine)
- Patients must be willing and able to be hospitalized, or to remain hospitalized (if
already hospitalized), for up to 16 days
- The investigator expects, at the time of enrollment, that the patient will be able to
be discharged from the hospital after the first 2 weeks of active treatment
- Disease symptoms must meet a certain range as assessed by the clinician
- Patients must have evidence of prominent negative symptoms of schizophrenia (i.e.
blunted affect, emotional withdrawal, or motor retardation)
- Patients must be considered reliable, have a level of understanding sufficient to
perform all tests and examinations required by the protocol, and be willing to
perform all study procedures
- Patients must be able to understand the nature of the study and have given their
informed consent
Exclusion Criteria:
- Patients who are actively suicidal
- Patients who are pregnant or nursing
- Patients who have had electroconvulsive therapy (ECT) within 3 months of screening or
who will have ECT at any time during the study
- Patients with uncorrected narrow-angle glaucoma, history of or current seizure
disorder, uncontrolled diabetes, certain diseases of the liver, uncontrolled thyroid
condition or other serious or unstable illnesses
- Patients with Parkinson's disease, psychosis related to dementia or related disorders
- Patients with known Human Immunodeficiency Virus positive (HIV+) status |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|